GlycoMimetics, Inc. GLYC
Set alert
15.71 0.00 0.00%
As of Jul 2, 3:58 PM ET
15.52 Day range 17.39
52-week range unavailable
- YTD
- -36.93%
- 1 year
- -41.94%
- Open
- 16.25
- Prev close
- 15.71
- Mkt cap
- 1.01B
- Vol
- 612
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 15.52
- High
- 17.39
- Forward P/E
- -2.41
- Beta
- 1.84
- Short ratio
- 1.07
- Inst. own
- 47.91%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Oct 2, 2024
- 50-d avg
- 0.2958
- 200-d avg
- 0.6851
- 1y target
- 1.00
Analyst view
Consensus: none
Price target (mean) 1.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 1
- 2 months ago 2
- 3 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | -0.14 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | -0.17 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | -0.58 | 0.0% | 0 | 0.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 26, 2024 | TD Cowen | Downgrade | Buy | Hold |
| Jun 4, 2024 | HC Wainwright & Co. | Reiterated | — | Neutral |
| May 6, 2024 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Mar 27, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Dec 22, 2023 | Capital One | Initiated | — | Overweight |
| Aug 3, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 15, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| May 4, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 30, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Feb 16, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Aug 4, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Nov 12, 2021 | Jefferies | Upgrade | Hold | Buy |
| Dec 8, 2020 | Roth Capital | Maintained | — | Buy |
| Jul 31, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Mar 2, 2020 | HC Wainwright & Co. | Reiterated | — | Buy |
| Nov 14, 2019 | Roth Capital | Initiated | — | Buy |
| Aug 5, 2019 | Jefferies | Downgrade | Buy | Hold |
| Aug 5, 2019 | SunTrust Robinson Humphrey | Downgrade | Buy | Hold |
| Aug 5, 2019 | Piper Sandler | Downgrade | Overweight | Neutral |
| Apr 12, 2019 | Piper Sandler | Initiated | — | Overweight |
| Dec 18, 2018 | HC Wainwright & Co. | Initiated | — | Buy |
| Mar 7, 2018 | Stifel | Maintained | Buy | Buy |
| Aug 15, 2016 | Cowen & Co. | Initiated | — | Outperform |
| Aug 5, 2016 | Stifel | Maintained | — | Buy |
| Jul 26, 2016 | SunTrust Robinson Humphrey | Initiated | — | Buy |
| Mar 17, 2015 | Stifel | Maintained | — | Buy |
| Apr 15, 2014 | Stifel | Maintained | — | Buy |
| Feb 4, 2014 | Stifel | Initiated | — | Buy |
| Feb 4, 2014 | Barclays | Initiated | — | Overweight |